Is LPTX or NOBL a better dividend investment in 2026?

LPTX currently yields 304.60% with a 5% 5-year dividend growth rate. NOBL yields 2.14% with 5% growth. The better choice depends on your goal: LPTX offers higher current income.

What is the dividend yield difference between LPTX and NOBL?

LPTX has a forward dividend yield of 304.60% ($2.00/share annually). NOBL yields 2.14% ($2.27/share annually). The yield gap is 302.46 percentage points.

Home › Compare › LPTX vs NOBL

LPTX vs NOBL: Dividend Comparison 2026

LPTX yields 304.60% · NOBL yields 2.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 LPTX wins by $1677.47M in total portfolio value

INVESTMENT

TIME HORIZON10 years

LPTX

● Live price

304.60%

Share price

$0.66

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$1677.50M

Annual income

$1,019,249,502.55

Full LPTX calculator →

NOBL

● Live price

2.14%

Share price

$106.01

Annual div

$2.27

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$22.8K

Annual income

$246.19

Full NOBL calculator →

Portfolio growth — LPTX vs NOBL

📍 LPTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	LPTX	NOBL
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, LPTX + NOBL cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

LPTX pays

NOBL pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

LPTX

Annual income on $10K today (after 15% tax)

$25,890.95/yr

After 10yr DRIP, annual income (after tax)

$866,362,077.17/yr

NOBL

Annual income on $10K today (after 15% tax)

$182.19/yr

After 10yr DRIP, annual income (after tax)

$209.26/yr

At 15% tax rate, LPTX beats the other by $866,361,867.91/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of LPTX + NOBL for your $10,000?

LPTX: 50%NOBL: 50%

100% NOBL50/50100% LPTX

Portfolio after 10yr

$838.76M

Annual income

$509,624,874.37/yr

Blended yield

60.76%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on LPTX right now

LPTX

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$5.50

+737.6% upside vs current

Range: $5.50 — $5.50

Altman Z

-1.9

Piotroski

4/9

NOBL

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

LPTX buys

NOBL buys

No recent congressional trades found for LPTX or NOBL in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricLPTXNOBL

Forward yield	304.60% ✓	2.14%
Annual dividend / share	$2.00	$2.27 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$1677.50M ✓	$22.8K
Annual income after 10y	$1,019,249,502.55 ✓	$246.19
Total dividends collected	$1611.81M ✓	$2.3K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: LPTX vs NOBL ($10,000, DRIP)

Year	LPTX Portfolio	LPTX Income/yr	NOBL Portfolio	NOBL Income/yr	Gap
1← crossover	$41,160	$30,459.95	$10,914	$214.34	+$30.2K → LPTX
2	$161,212	$117,171.00	$11,897	$218.63	+$149.3K → LPTX
3	$601,400	$428,903.22	$12,952	$222.72	+$588.4K → LPTX
4	$2,138,843	$1,495,344.84	$14,086	$226.62	+$2.12M → LPTX
5	$7,258,751	$4,970,189.23	$15,302	$230.33	+$7.24M → LPTX
6	$23,531,071	$15,764,207.60	$16,607	$233.85	+$23.51M → LPTX
7	$72,938,668	$47,760,421.89	$18,007	$237.18	+$72.92M → LPTX
8	$216,401,174	$138,356,798.39	$19,508	$240.35	+$216.38M → LPTX
9	$615,184,508	$383,635,252.06	$21,116	$243.35	+$615.16M → LPTX
10	$1,677,496,926	$1,019,249,502.55	$22,841	$246.19	+$1677.47M → LPTX

LPTX vs NOBL: Complete Analysis 2026

LPTX — Stock

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap Therapeutics, Inc. has an option and license agreement with BeiGene, Ltd. to develop and commercialize DKN-01 in Asia (excluding Japan), Australia, and New Zealand. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

Full LPTX Calculator →

NOBL — ETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →

📬

Get this LPTX vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

LPTX vs SCHD LPTX vs JEPI LPTX vs O LPTX vs KO LPTX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.